Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy.

Autor: Oppenheim, D E1, Spreafico, R2, Etuk, A2, Malone, D2, Amofah, E2, Peña-Murillo, C2, Murray, T2, McLaughlin, L2, Choi, B S2, Allan, S3, Belousov, A4, Passioukov, A5, Gerdes, C5, Umaña, P5, Farzaneh, F1, Ross, P6
Zdroj: British Journal of Cancer. 3/4/2014, Vol. 110 Issue 5, p1221-1227. 7p. 2 Color Photographs, 1 Black and White Photograph, 6 Graphs.
Databáze: Academic Search Ultimate